Kulturgeschichte - Zheng He, der Kolumbus der Chinesen wienerzeitung.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wienerzeitung.at Daily Mail and Mail on Sunday newspapers.
According to various sources, Chilean and Spanish wines are presented as the best candidates to fill the void left in China by wines from Australia, victims of an import collapse due to the recent imposition of tariffs of up to 218 percent.
These are five-year levies, in force since Mar. 28, which replaced other temporary ones for five months that Chinese authorities imposed on Australian bottled wine while they finalized an investigation for alleged unfair competition and selling at a loss. It comes at a time relations between Beijing and Canberra are at a low.
The impact of these measures is beginning to be felt and, according to statistics from the National Customs Administration of China in the first quarter of the year. Chile has already surpassed Australia in both wine export volume and value (the South American country is now second in both categories, behind France.)
Chile, Spain, addressing the void left by Australian wine in China 3 minutes read
By Javier Triana
Beijing, May 5 (EFE).- According to various sources, Chilean and Spanish wines are presented as the best candidates to fill the void left in China by wines from Australia, victims of an import collapse due to the recent imposition of tariffs of up to 218 percent.
These are five-year levies, in force since Mar. 28, which replaced other temporary ones for five months that Chinese authorities imposed on Australian bottled wine while they finalized an investigation for alleged unfair competition and selling at a loss. It comes at a time relations between Beijing and Canberra are at a low.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The sales of hydroxychloroquine in the Chinese market have been rising steadily, from CNY 258 million in 2016 to CNY 343 million in 2020, with a CAGR of 7.34% from 2016 to 2020. In 2020, China s sales of hydroxychloroquine were CNY 343 million, a slight increase of 0.71% than 2019.
Hydroxychloroquine is commonly used to prevent and treat malaria. The pharmacokinetics of hydroxychloroquine is similar to that of chloroquine. It can be rapidly absorbed in the gastrointestinal tract and excreted in the kidneys. Hydroxychloroquine is also used in the treatment of rheumatoid arthritis, lupus erythematosus, and delayed skin lesions purpura.
The market demand for hydroxychloroquine in China is relatively large. There are two companies approved for manufacturing hydroxychloroquine, namely Shanghai Zhongxi Pharmaceutical Co., Ltd. and Sanofi-aventis Ireland Ltd. Shanghai Zhongxi Pharmaceutical Co., Ltd. has a larger